Tian Yang, USPTO Patent Examiner

Listed by the USPTO as YANG, TIAN

Tech Center 1600 • Art Units: 1674

This examiner grants 0% of resolved cases

Performance Statistics

—

Allow Rate

-60.0% vs TC avg

Total Applications

—

Interview Lift

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

§101 Eligibility

23.1%

§102 Novelty

34.6%

§103 Obviousness

42.3%

§112 Clarity

App #	Title	Status	Assignee
18266717	METHODS OF TREATING DIABETES	Non-Final OA	Eli Lilly and Company
18554236	COMBINATION THERAPY WITH A RAF INHIBITOR AND A PD-1 AXIS INHIBITOR	Non-Final OA	Hanmi Pharm. Co., Ltd.
18274754	CANCER THERAPY	Non-Final OA	SURGE Therapeutics, Inc.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Tian Yang examines applications in Art Unit 1674 in Tech Center 1600 (Biotechnology & Pharmaceuticals).